Join us this Tuesday for our monthly Salon Series. We rescheduled this month's topic due to popular demand.
Don't miss participating in what will be a fascinating discussion!
Featured Facilitator, Camden Swita, Editor of Pacifica.Patch.
Read Camden's article:
"Your Life Online" Social Media - We'll discuss all aspects of online behavior in the social media space.
Join us for an evening of lively conversation!
Wine & Conversation: Your Life Online
Pacifica See map
Comments + Leave a Comment
Loading comments ...
Boards
All Boards »
Janet Arline Barker May 17, 2013 at 11:18 am
Awesome! Next Tuesday, Thursday or Friday are open. Name a time and place. I used to write 3…Read More different columns for San Bruno, Millbrae, and Burlingame Patch. I am ready to write for Pacifica Patch & blog too. Here's my personal blog...I do sporadically. Www.art-Janet.blogspot.com
My art studio is at Sanchez Art Center #11
Christa Bigue (Editor) May 17, 2013 at 11:05 am
When can we meet for coffee Janet? Since you're the first one to post in our biz update section you…Read More get to have coffee and chat with your local Patch editor! Email me at christa.bigue@patch.com and we'll find a date and place.
Anon. April 14, 2013 at 01:43 am
I can start with the comments on the Theravance drug, fluticasone fluroate - the active moiety in…Read More this compound is the same, fluticasone (proprionate) that has been marketed by GSK for the same indication for approximately 25 years. Indeed, that patent is so old, and the drug has such a proven track record for safety and efficacy, that the patent has expired and there are generic versions available.
There is also in implicit assumption by the author that the only reason that the FDA will approve medications in a short time span is because they are for 'life-or-limb' or unmet serious medical need. This is just not the case - regulators in many countries, including the FDA in the USA, may give accelerated approval to a product, where the safety and tolerability of a product is equivalent to a similar active agent which has already been approved. I suspect this is the case for fluticasone fluroate - but I am not privy to the details of the regulatory filing.
I note that none of the companies mentioned here, nor the FDA, has provided input to this article.
The journalism in this article smacks of someone trying to make a name for themselves quickly by scaring uneducated and/or anxious people.
The science is just plain flawed.
Stacie Chan (Editor) March 26, 2013 at 02:51 pm
Absolutely stunning photos, Deb! Thanks for sharing. I really feel like I was there by just perusing…Read More your photo gallery.